165 related articles for article (PubMed ID: 11673348)
1. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
[TBL] [Abstract][Full Text] [Related]
2. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation.
Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ
Eur J Cardiothorac Surg; 2002 Nov; 22(5):733-7. PubMed ID: 12414039
[TBL] [Abstract][Full Text] [Related]
3. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
[TBL] [Abstract][Full Text] [Related]
4. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
[TBL] [Abstract][Full Text] [Related]
5. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
[TBL] [Abstract][Full Text] [Related]
6. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
[TBL] [Abstract][Full Text] [Related]
7. Dose dependent effects of cardiac beta2 adrenoceptor gene therapy.
Jones JM; Wilson KH; Steenbergen C; Koch WJ; Milano CA
J Surg Res; 2004 Nov; 122(1):113-20. PubMed ID: 15522323
[TBL] [Abstract][Full Text] [Related]
8. Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts.
Tevaearai HT; Eckhart AD; Walton GB; Keys JR; Wilson K; Koch WJ
Circulation; 2002 Jul; 106(1):124-9. PubMed ID: 12093781
[TBL] [Abstract][Full Text] [Related]
9. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
[TBL] [Abstract][Full Text] [Related]
10. beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery.
Jones JM; Petrofski JA; Wilson KH; Steenbergen C; Koch WJ; Milano CA
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1161-8. PubMed ID: 15541978
[TBL] [Abstract][Full Text] [Related]
11. Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure.
Li Z; Laugwitz KL; Pinkernell K; Pragst I; Baumgartner C; Hoffmann E; Rosport K; Münch G; Moretti A; Humrich J; Lohse MJ; Ungerer M
Gene Ther; 2003 Aug; 10(16):1354-61. PubMed ID: 12883532
[TBL] [Abstract][Full Text] [Related]
12. Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure.
Tachibana H; Naga Prasad SV; Lefkowitz RJ; Koch WJ; Rockman HA
Circulation; 2005 Feb; 111(5):591-7. PubMed ID: 15668342
[TBL] [Abstract][Full Text] [Related]
13. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes.
Eckhart AD; Koch WJ
Mol Ther; 2002 Jan; 5(1):74-9. PubMed ID: 11786048
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary adenovirus-mediated delivery and overexpression of the beta(2)-adrenergic receptor in the heart : prospects for molecular ventricular assistance.
Shah AS; Lilly RE; Kypson AP; Tai O; Hata JA; Pippen A; Silvestry SC; Lefkowitz RJ; Glower DD; Koch WJ
Circulation; 2000 Feb; 101(4):408-14. PubMed ID: 10653833
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the cardiac beta(2)-adrenergic receptor and expression of a beta-adrenergic receptor kinase-1 (betaARK1) inhibitor both increase myocardial contractility but have differential effects on susceptibility to ischemic injury.
Cross HR; Steenbergen C; Lefkowitz RJ; Koch WJ; Murphy E
Circ Res; 1999 Nov; 85(11):1077-84. PubMed ID: 10571539
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
[TBL] [Abstract][Full Text] [Related]
18. ATP-sensitive potassium channel activation before cardioplegia. Effects on ventricular and myocyte function.
Dorman BH; Hebbar L; Zellner JL; New RB; Houck WV; Acsell J; Nettles C; Hendrick JW; Sampson AP; Mukherjee R; Spinale FG
Circulation; 1998 Nov; 98(19 Suppl):II176-83. PubMed ID: 9852901
[TBL] [Abstract][Full Text] [Related]
19. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528
[TBL] [Abstract][Full Text] [Related]
20. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
Anderson KM; Eckhart AD; Willette RN; Koch WJ
Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
